loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Abivertinib, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Abivertinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

    One Pharma aims to be one of the leading generic companies in Europe.

    2D Structure
    1. Also known as: Avitinib, 1557267-42-1, Ac0010, N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7h-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide, Ex-acea0010, Abivertinib [usan]
    Molecular Formula
    C26H26FN7O2
    Molecular Weight
    487.5  g/mol
    InChI Key
    UOFYSRZSLXWIQB-UHFFFAOYSA-N
    FDA UNII
    CER0OPG92L
    Abivertinib is an orally available, irreversible, epidermal growth factor receptor (EGFR) mutant-selective inhibitor, with potential antineoplastic activity. Upon oral administration, abivertinib covalently binds to and inhibits the activity of mutant forms of EGFR, including the drug-resistant T790M EGFR mutant, which prevents signaling mediated by mutant forms of EGFR. This may both induce cell death and inhibit tumor growth in EGFR-mutated tumor cells. EGFR, a receptor tyrosine kinase that is mutated in a variety of cancers, plays a key role in tumor cell proliferation and tumor vascularization. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced when compared to non-selective EGFR inhibitors, which also inhibit wild-type EGFR.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide
    2.1.2 InChI
    InChI=1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32)
    2.1.3 InChI Key
    UOFYSRZSLXWIQB-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F
    2.2 Other Identifiers
    2.2.1 UNII
    CER0OPG92L
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-propenamide, N-(3-((2-((3-fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7h-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)-

    2. 2-propenamide, N-(3-((2-((3-fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7h-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)-, (2z)-2-butenedioate (1:1)

    3. 2-propenamide, N-(3-((2-((3-fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7h-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)-, (2z)-2-butenedioate, Hydrate (1:1:2)

    4. A-610ma

    5. A610ma

    6. Abivertinib Maleate

    7. Abivertinib Maleate Anhydrous

    8. Abivertinib Maleate Dihydrate

    9. Ac-0010

    10. Ac-0010 Maleate Dihydrate

    11. Ac-0010ma

    12. Ac0010

    13. Ac0010ma

    14. Acea100610

    15. Avitinib

    16. Avitinib Maleate

    17. Ex-acea0010

    18. Ex-acea0010ma

    19. Exacea0010ma

    20. Fujovee

    21. N-(3-((2-((3-fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7h-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)acrylamide

    22. Sti-5656

    23. Sti5656

    2.3.2 Depositor-Supplied Synonyms

    1. Avitinib

    2. 1557267-42-1

    3. Ac0010

    4. N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7h-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide

    5. Ex-acea0010

    6. Abivertinib [usan]

    7. Acea100610

    8. Cer0opg92l

    9. Ac-0010

    10. A610

    11. Abivertinib (usan)

    12. 1557267-42-1 (free Base)

    13. N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7h-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide

    14. 2-propenamide, N-(3-((2-((3-fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7h-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)-

    15. 2-propenamide, N-[3-[[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-7h-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]-

    16. N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7h-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide

    17. N-(3-{2-[3-fluoro-4-(4-methyl-piperazin-1-yl)-phenylamino]-7h-pyrrolo[2,3-d]pyrimidin-4-yloxy-phenyl)-acrylamide

    18. Avitinib Free Base

    19. Fujovee

    20. Avitinib (ac0010)

    21. Unii-cer0opg92l

    22. Abivertinib [inn]

    23. Avitinib (superceded Inn)

    24. Avitinib [who-dd]

    25. Abivertinib [who-dd]

    26. Chembl4297865

    27. Schembl15453394

    28. Gtpl10044

    29. Ex-a783

    30. Bdbm294480

    31. Avitinib(ac0010/ac0010ma)

    32. Bcp16381

    33. Us9586965, Cpd 3

    34. Mfcd29089376

    35. S8741

    36. Zinc142081723

    37. Ac 0010

    38. Cs-w008904

    39. Db15327

    40. Ac-35320

    41. Ds-19269

    42. Hy-19816

    43. N-(3-{2-[3-fluoro-4-(4-methyl-piperazin-1-yl)-phenylamino]-7h-pyrrolo[2,3-d]pyrimidin-4-yloxy}-phenyl)-acrylamide

    44. Cs-0016789

    45. A16826

    46. D11308

    47. F17427

    48. A927386

    49. N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1- Yl)phenyl)amino)-7h-pyrrolo[2,3-d]- Pyrimidin-4-yl)oxy)phenyl)acrylamide

    50. N-(3-(2-(3-fluoro-4-(4-methylpiperazin-1-yl)phenylamino)-7h-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl)acrylamide

    51. N-[3-[[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-7h-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide

    2.4 Create Date
    2014-02-18
    3 Chemical and Physical Properties
    Molecular Weight 487.5 g/mol
    Molecular Formula C26H26FN7O2
    XLogP34.2
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count7
    Exact Mass487.21320126 g/mol
    Monoisotopic Mass487.21320126 g/mol
    Topological Polar Surface Area98.4 Ų
    Heavy Atom Count36
    Formal Charge0
    Complexity752
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Protein Kinase Inhibitors

    Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)

    Post Enquiry
    POST ENQUIRY